Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.59 -0.04 (-6.35%)
At close: Oct 23, 2026 · 4:00 PM EDT

Bluejay Diagnostics (BJDX) Cost of Revenue (2022)

Updated

Bluejay Diagnostics (BJDX) posted Cost of Revenue of $200,129 for FY2022.

Analysis

Bluejay Diagnostics (BJDX) Cost of Revenue (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Thermo Fisher Scientific 249.17 Bn 228.32 Bn 4.88 Bn 7.11 Bn
2 Abbott Laboratories 179.42 Bn 150.51 Bn 7.27 Bn 5.33 Bn
3 Danaher 161.98 Bn 145.80 Bn 3.61 Bn 2.65 Bn
4 Intuitive Surgical 156.76 Bn 137.18 Bn 2.08 Bn 964.40 Mn
5 Medtronic 122.13 Bn 88.00 Bn 6.34 Bn 3.42 Bn
6 Stryker 117.84 Bn 103.96 Bn 4.50 Bn 2.09 Bn
7 Boston Scientific 66.19 Bn 61.20 Bn 3.85 Bn 1.59 Bn
8 Becton Dickinson 54.16 Bn 51.31 Bn 2.32 Bn 2.67 Bn
9 Edwards Lifesciences 51.35 Bn 35.47 Bn 1.35 Bn 392.40 Mn
10 Bluejay Diagnostics 1.17 Mn -20.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 200,129.00
API Access

Bluejay Diagnostics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BJDX&period=max&api_key=YOUR_API_KEY